| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | George W Booz | |
| Mazen Kurdi | |||
| P2860 | cites work | Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 |
| Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. | Q50734767 | ||
| The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. | Q51168559 | ||
| Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. | Q51372632 | ||
| Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. | Q53576712 | ||
| Stem cells and their potential in cell-based cardiac therapies | Q28302056 | ||
| Stem cell niches in the adult mouse heart | Q34657903 | ||
| The bone marrow--cardiac axis of myocardial regeneration | Q36174197 | ||
| A novel two-step procedure to expand cardiac Sca-1+ cells clonally. | Q36274962 | ||
| Cardiac regeneration by resident stem and progenitor cells in the adult heart. | Q36704752 | ||
| The potential of cardiac stem cell therapy for heart failure | Q36727011 | ||
| Cellular transplantation: future therapeutic options | Q36729975 | ||
| Progenitor cells for cardiac repair | Q36744760 | ||
| Can the cardiomyocyte cell cycle be reprogrammed? | Q36760711 | ||
| Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting | Q36798906 | ||
| Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure. | Q36802233 | ||
| Stem cells and the regeneration of the aging cardiovascular system | Q36803362 | ||
| Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies? | Q36814737 | ||
| Adult stem cells and heart regeneration | Q36815983 | ||
| The role of endothelial progenitor cells in ischemic cerebral and heart diseases | Q36822315 | ||
| The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases | Q36837492 | ||
| Therapeutic angiogenesis with bone marrow--derived stem cells | Q36847077 | ||
| Endogenous cardiac stem cells. | Q36881862 | ||
| Stem cell therapies for heart disease: why do we need bioengineers? | Q36900399 | ||
| G-CSF-based stem cell therapy for the heart-unresolved issues part A: paracrine actions, mobilization, and delivery | Q36900787 | ||
| A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. | Q42688498 | ||
| P433 | issue | 6 | |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 347-351 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Congestive Heart Failure | Q15756697 |
| P1476 | title | G-CSF-based stem cell therapy for the heart--unresolved issues part B: Stem cells, engraftment, transdifferentiation, and bioengineering | |
| P478 | volume | 13 |
Search more.